Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 21, 18 Issues, 2021
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 11 - Number 5
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)]
, 11(5): 408 - 410Susanne Sebens and Holger Kalthoff
DOI: 10.2174/187152011795677418
An Update on Molecular Research of Pancreatic Adenocarcinoma
, 11(5): 411 - 417Christian Krautz, Felix Ruckert, Hans-Detlev Saeger, Christian Pilarsky and Robert Grutzmann
DOI: 10.2174/187152011795677409
Combination Therapy for the Treatment of Pancreatic Cancer
, 11(5): 418 - 426William Greenhalf and Amy Thomas
DOI: 10.2174/187152011795677391
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
, 11(5): 427 - 433Simon Rieder, Christoph W. Michalski, Helmut Friess and > Kleeff
DOI: 10.2174/187152011795677454
Aptamers: Potential Applications to Pancreatic Cancer Therapy
, 11(5): 434 - 441Kristy L. Rialon and Rebekah R. White
DOI: 10.2174/187152011795677472
Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?
, 11(5): 448 - 454Hubert G. Hotz, Birgit Hotz and Heinz-Johannes Buhr
DOI: 10.2174/187152011795677436
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
, 11(5): 455 - 463Marco Falasca, Federico Selvaggi, Richard Buus, Sara Sulpizio and Charlotte E. Edling
DOI: 10.2174/187152011795677382
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
, 11(5): 464 - 469Murwarid M. Assifi and Oscar J. Hines
DOI: 10.2174/187152011795677463
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
, 11(5): 470 - 478Nicholas J. Zyromski and Patrick B. White
DOI: 10.2174/187152011795677445
Editor-in-Chief
Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)
Biography
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
Biography
Biography of Simone Carradori
Dr. Simone Carradori, after completing graduation in “Drug Chemistry and Technology”, obtained
his PhD in “Pharmaceutical Sciences” at the University of Rome "La Sapienza" (Italy). He
collaborates with several departments abroad. Currently, he is assistant professor at the Department
of Pharmacy of “G. d’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is
mainly focused on the synthesis and characterization of heterocyclic derivatives as well as
extraction of natural compounds with potential biological activity, and is documented from several
papers in international peer-reviewed journals, one European patent and participations in numerous
conferences.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 2.38
Webmaster Contact: info@benthamscience.net